+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Kidney Disease Market - Global Forecast 2025-2030- Product Image
Chronic Kidney Disease Market - Global Forecast 2025-2030- Product Image
Sale

Chronic Kidney Disease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977705
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The chronic kidney disease market is rapidly evolving as global healthcare systems address escalating patient needs, emerging technologies, and complex regulatory landscapes. Industry leaders must navigate shifting therapeutic, operational, and economic priorities to sustain growth and drive improved patient outcomes.

Market Snapshot: Chronic Kidney Disease Market Size and Growth

The Chronic Kidney Disease Market grew from USD 136.56 billion in 2024 to USD 145.75 billion in 2025. It is expected to continue growing at a CAGR of 6.54%, reaching USD 199.77 billion by 2030. This upward trajectory reflects advances in diagnostics, rising prevalence, expanding treatment options, and increased investment in value-based care.

Scope & Segmentation

  • Therapy Type: Diagnostics (Imaging, Laboratory), Dialysis (Hemodialysis, Peritoneal), Pharmaceuticals (Antihypertensives, Erythropoietin Stimulating Agents, Iron Supplements, Phosphate Binders), and Transplantation
  • Disease Stage: Early, Moderate, Severe, End Stage Renal Disease
  • End User: Ambulatory Care Clinics, Dialysis Centers, Home Care, Hospitals
  • Product: Consumables (Catheters, Needles, Filters, Dialyzers), Equipment (Hemodialysis Machines, Peritoneal Dialysis Cyclers), Monitoring Devices (Blood Testing, Imaging Systems)
  • Patient Type: Adult, Pediatric
  • Regions: Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major European and emerging markets), Asia-Pacific (including China, India, Japan, Australia, South Korea, and other fast-developing countries)
  • Key Companies: Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Medtronic plc, Diaverum AB, NxStage Medical, Inc., Terumo Corporation, Quanta Dialysis Technologies Ltd.

Key Takeaways for Senior Decision-Makers

  • Multimodal therapies—including advanced dialysis modalities, pharmaceutical innovations, and transplantation—are reshaping patient pathways and broadening treatment paradigms.
  • Digital health platforms and AI-enabled analytics are enhancing real-time monitoring, risk stratification, and therapy adherence, supporting early clinical intervention and operational efficiencies.
  • Integrated care models leverage cross-disciplinary teams to align physical, psychosocial, and logistical support for improved patient engagement.
  • Segment-specific drivers such as comorbidity management, stage-specific interventions, and tailored products for adult and pediatric needs demand nuanced strategic approaches.
  • Strategic collaborations between industry, research institutions, and technology firms accelerate pipeline development and product innovation across regions.
  • Regional variations require localized strategies, with emerging markets focusing on scalable, cost-sensitive solutions and mature markets investing in cutting-edge applications and integrated service delivery.

Tariff Impact: Navigating Trade Policy Changes

Recent United States tariff measures have directly affected the chronic kidney disease treatment supply chain, increasing costs for essential medical products such as dialysis equipment, consumables, and certain pharmaceuticals. Healthcare providers and manufacturers are actively exploring alternative sourcing, local assembly, and supply chain diversification to manage tariff-induced expenses and ensure continuity of care. These adjustments also create renewed emphasis on supply chain agility and cost optimization for stakeholders.

Methodology & Data Sources

This market intelligence draws on a comprehensive literature review complemented by primary interviews with nephrology experts, healthcare executives, and policymakers. Insights from peer-reviewed journals, clinical trial registries, and healthcare databases were rigorously synthesized and validated through cross-source triangulation, thematic coding, and expert advisory input, ensuring reliability and practical relevance.

Why This Report Matters: Outcomes for Senior Leaders

  • Enables confident strategic planning by providing actionable segmentation, technology, and regional insights aligned with shifting care models and policy directives.
  • Supports resilience initiatives by elucidating supply chain risks, tariff impacts, and innovation trends crucial for business continuity.
  • Fosters informed investment by clarifying the relevance of emerging technologies, care integration, and regulatory frameworks for future growth opportunities.

Conclusion

Advances in chronic kidney disease care are influenced by technology adoption, shifting policy, and evolving patient needs. Robust, data-driven market intelligence empowers industry leaders to capitalize on emerging opportunities, balance risk, and guide long-term strategic success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of point-of-care molecular biomarkers for early CKD detection in underserved populations
5.2. Growing investment in gene therapy approaches targeting renal fibrosis reversal in chronic kidney disease patients
5.3. Expansion of home-based dialysis technologies offering telemonitoring and personalized treatment adjustments
5.4. Emergence of wearable renal monitoring devices using real-time analytics to track patient hydration and electrolyte balance
5.5. Development of precision medicine pipelines utilizing genomics data to stratify CKD patient treatment pathways
5.6. Integration of digital therapeutics and patient engagement platforms to improve adherence in CKD management programs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Chronic Kidney Disease Market, by Therapy Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Imaging Diagnostics
8.2.2. Laboratory Diagnostics
8.3. Dialysis
8.3.1. Hemodialysis
8.3.2. Peritoneal Dialysis
8.4. Pharmaceuticals
8.4.1. Antihypertensives
8.4.2. Erythropoietin Stimulating Agents
8.4.2.1. Darbepoetin Alfa
8.4.2.2. Epoetin Alfa
8.4.3. Iron Supplements
8.4.4. Phosphate Binders
8.5. Transplantation
9. Chronic Kidney Disease Market, by Disease Stage
9.1. Introduction
9.2. Early Disease
9.3. End Stage Renal Disease
9.4. Moderate Disease
9.5. Severe Disease
10. Chronic Kidney Disease Market, by End User
10.1. Introduction
10.2. Ambulatory Care Clinic
10.3. Dialysis Center
10.4. Home Care
10.5. Hospital
11. Chronic Kidney Disease Market, by Product
11.1. Introduction
11.2. Consumables
11.2.1. Catheters & Needles
11.2.2. Filters & Dialyzers
11.3. Equipment
11.3.1. Hemodialysis Machine
11.3.2. Peritoneal Dialysis Cycler
11.4. Monitoring Devices
11.4.1. Blood Testing Devices
11.4.2. Imaging Systems
12. Chronic Kidney Disease Market, by Patient Type
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Chronic Kidney Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Chronic Kidney Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Chronic Kidney Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fresenius Medical Care AG & Co. KGaA
16.3.2. DaVita Inc.
16.3.3. Baxter International Inc.
16.3.4. B. Braun Melsungen AG
16.3.5. Nipro Corporation
16.3.6. Medtronic plc
16.3.7. Diaverum AB
16.3.8. NxStage Medical, Inc.
16.3.9. Terumo Corporation
16.3.10. Quanta Dialysis Technologies Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CHRONIC KIDNEY DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CHRONIC KIDNEY DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CHRONIC KIDNEY DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CHRONIC KIDNEY DISEASE MARKET: RESEARCHAI
FIGURE 26. CHRONIC KIDNEY DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 27. CHRONIC KIDNEY DISEASE MARKET: RESEARCHCONTACTS
FIGURE 28. CHRONIC KIDNEY DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHRONIC KIDNEY DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DARBEPOETIN ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EPOETIN ALFA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IRON SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHOSPHATE BINDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHOSPHATE BINDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EARLY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EARLY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END STAGE RENAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END STAGE RENAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MODERATE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MODERATE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SEVERE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY SEVERE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY CARE CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY AMBULATORY CARE CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CATHETERS & NEEDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CATHETERS & NEEDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FILTERS & DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY FILTERS & DIALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS MACHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY HEMODIALYSIS MACHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS CYCLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PERITONEAL DIALYSIS CYCLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY BLOOD TESTING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CHRONIC KIDNEY DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 154. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 155. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 156. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 157. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 158. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 159. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 162. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 163. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 166. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 167. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 168. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 169. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 170. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 171. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 172. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 173. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 194. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CHRONIC KIDNEY DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2018-2024 (USD MILLION)
TABLE 302. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIALYSIS, 2025-2030 (USD MILLION)
TABLE 303. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 304. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 305. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY ERYTHROPOIETIN STIMULATING AGENTS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 308. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 312. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 313. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 314. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 315. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
TABLE 316. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
TABLE 317. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 318. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 319. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 320. GERMANY CHRONIC KIDNEY DISEASE MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 322. FRANCE CHRONIC KIDNEY DISEASE MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 323. FRANCE CHRONIC KIDNEY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 324.

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Chronic Kidney Disease market report include:
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Medtronic plc
  • Diaverum AB
  • NxStage Medical, Inc.
  • Terumo Corporation
  • Quanta Dialysis Technologies Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 145.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 199.77 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Chronic Kidney Disease Medication Market - Global Forecast 2025-2030 - Product Image

Chronic Kidney Disease Medication Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Chronic Kidney Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Chronic Kidney Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Kidney Disease Market Report 2025 - Product Image

Kidney Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market Report 2025 - Product Image

Chronic Kidney Disease Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Digital Platform for Chronic Kidney Disease Market - Global Forecast 2025-2030 - Product Image

Digital Platform for Chronic Kidney Disease Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.